Literature DB >> 29373038

Actin polymerization contributes to enhanced pulmonary vasoconstrictor reactivity after chronic hypoxia.

Laura Weise-Cross1, Michelle A Sands1, Joshua R Sheak1, Brad R S Broughton1, Jessica B Snow1, Laura V Gonzalez Bosc1, Nikki L Jernigan1, Benjimen R Walker1, Thomas C Resta1.   

Abstract

Chronic hypoxia (CH) augments basal and endothelin-1 (ET-1)-induced pulmonary vasoconstrictor reactivity through reactive oxygen species (ROS) generation and RhoA/Rho kinase (ROCK)-dependent myofilament Ca2+ sensitization. Because ROCK promotes actin polymerization and the actin cytoskeleton regulates smooth muscle tension, we hypothesized that actin polymerization is required for enhanced basal and ET-1-dependent vasoconstriction after CH. To test this hypothesis, both end points were monitored in pressurized, endothelium-disrupted pulmonary arteries (fourth-fifth order) from control and CH (4 wk at 0.5 atm) rats. The actin polymerization inhibitors cytochalasin and latrunculin attenuated both basal and ET-1-induced vasoconstriction only in CH vessels. To test whether CH directly alters the arterial actin profile, we measured filamentous actin (F-actin)-to-globular actin (G-actin) ratios by fluorescent labeling of F-actin and G-actin in fixed pulmonary arteries and actin sedimentation assays using homogenized pulmonary artery lysates. We observed no difference in actin polymerization between groups under baseline conditions, but ET-1 enhanced actin polymerization in pulmonary arteries from CH rats. This response was blunted by the ROS scavenger tiron, the ROCK inhibitor fasudil, and the mDia (RhoA effector) inhibitor small-molecule inhibitor of formin homology domain 2. Immunoblot analysis revealed an effect of CH to increase both phosphorylated (inactive) and total levels of the actin disassembly factor cofilin but not phosphorylated cofilin-to-total cofilin ratios. We conclude that actin polymerization contributes to increased basal pulmonary arterial constriction and ET-1-induced vasoconstrictor reactivity after CH in a ROS- and ROCK-dependent manner. Our results further suggest that enhanced ET-1-mediated actin polymerization after CH is dependent on mDia but independent of changes in the phosphorylated cofilin-to-total cofilin ratio. NEW & NOTEWORTHY This research is the first to demonstrate a role for actin polymerization in chronic hypoxia-induced basal pulmonary arterial constriction and enhanced agonist-induced vasoconstrictor activity. These results suggest that a reactive oxygen species-Rho kinase-actin polymerization signaling pathway mediates this response and may provide a mechanistic basis for the vasoconstrictor component of pulmonary hypertension.

Entities:  

Keywords:  Rho kinase; actin polymerization; chronic hypoxia; pulmonary hypertension; reactive oxygen species

Mesh:

Substances:

Year:  2018        PMID: 29373038      PMCID: PMC6008138          DOI: 10.1152/ajpheart.00664.2017

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  50 in total

1.  A new method for direct detection of the sites of actin polymerization in intact cells and its application to differentiated vascular smooth muscle.

Authors:  Hak Rim Kim; Paul C Leavis; Philip Graceffa; Cynthia Gallant; Kathleen G Morgan
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-04       Impact factor: 4.249

Review 2.  Physiological roles of Rho and Rho effectors in mammals.

Authors:  Dean Thumkeo; Sadanori Watanabe; Shuh Narumiya
Journal:  Eur J Cell Biol       Date:  2013-10-08       Impact factor: 4.492

3.  Kinase-dependent activation of voltage-gated Ca2+ channels by ET-1 in pulmonary arterial myocytes during chronic hypoxia.

Authors:  Trevor Luke; Julie Maylor; Clark Undem; J T Sylvester; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-02       Impact factor: 5.464

Review 4.  Regulation of myosin light chain phosphatase and pulmonary arterial relaxation.

Authors:  Shyamala Dakshinamurti
Journal:  Can J Physiol Pharmacol       Date:  2005-10       Impact factor: 2.273

5.  Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.

Authors:  Masahiko Oka; Noriyuki Homma; Laimute Taraseviciene-Stewart; Kenneth G Morris; Donatas Kraskauskas; Nana Burns; Norbert F Voelkel; Ivan F McMurtry
Journal:  Circ Res       Date:  2007-03-01       Impact factor: 17.367

6.  Actin depolymerization factor/cofilin activation regulates actin polymerization and tension development in canine tracheal smooth muscle.

Authors:  Rong Zhao; Liping Du; Youliang Huang; Yidi Wu; Susan J Gunst
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

7.  Enhanced depolarization-induced pulmonary vasoconstriction following chronic hypoxia requires EGFR-dependent activation of NAD(P)H oxidase 2.

Authors:  Charles E Norton; Brad R S Broughton; Nikki L Jernigan; Benjimen R Walker; Thomas C Resta
Journal:  Antioxid Redox Signal       Date:  2012-10-18       Impact factor: 8.401

Review 8.  Physiologic properties and regulation of the actin cytoskeleton in vascular smooth muscle.

Authors:  Dale D Tang; Yana Anfinogenova
Journal:  J Cardiovasc Pharmacol Ther       Date:  2008-01-22       Impact factor: 2.457

9.  Effect of cytochalasin B on intestinal smooth muscle cells.

Authors:  K Obara; H Yabu
Journal:  Eur J Pharmacol       Date:  1994-04-01       Impact factor: 4.432

10.  Chronic hypoxia induces Rho kinase-dependent myogenic tone in small pulmonary arteries.

Authors:  Brad R S Broughton; Benjimen R Walker; Thomas C Resta
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-02-08       Impact factor: 5.464

View more
  7 in total

1.  AJP-Regulatory, Integrative and Comparative Physiology: Looking Toward the Future.

Authors:  Gina L C Yosten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-05-06       Impact factor: 3.619

2.  Intermittent Hypoxia Augments Pulmonary Vasoconstrictor Reactivity through PKCβ/Mitochondrial Oxidant Signaling.

Authors:  Jessica B Snow; Charles E Norton; Michelle A Sands; Laura Weise-Cross; Simin Yan; Lindsay M Herbert; Joshua R Sheak; Laura V Gonzalez Bosc; Benjimen R Walker; Nancy L Kanagy; Nikki L Jernigan; Thomas C Resta
Journal:  Am J Respir Cell Mol Biol       Date:  2020-06       Impact factor: 6.914

3.  PKCβ and reactive oxygen species mediate enhanced pulmonary vasoconstrictor reactivity following chronic hypoxia in neonatal rats.

Authors:  Joshua R Sheak; Simin Yan; Laura Weise-Cross; Rosstin Ahmadian; Benjimen R Walker; Nikki L Jernigan; Thomas C Resta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-01-10       Impact factor: 4.733

4.  Oxidative stress generated by polycyclic aromatic hydrocarbons from ambient particulate matter enhance vascular smooth muscle cell migration through MMP upregulation and actin reorganization.

Authors:  Sujin Ju; Leejin Lim; Young-Jae Ki; Dong-Hyun Choi; Heesang Song
Journal:  Part Fibre Toxicol       Date:  2022-04-22       Impact factor: 9.112

5.  PHD2 deletion in endothelial or arterial smooth muscle cells reveals vascular cell type-specific responses in pulmonary hypertension and fibrosis.

Authors:  Harri Elamaa; Mika Kaakinen; Marjut Nätynki; Zoltan Szabo; Veli-Pekka Ronkainen; Ville Äijälä; Joni M Mäki; Risto Kerkelä; Johanna Myllyharju; Lauri Eklund
Journal:  Angiogenesis       Date:  2022-01-08       Impact factor: 10.658

6.  Stromal vascular fraction promotes migration of fibroblasts and angiogenesis through regulation of extracellular matrix in the skin wound healing process.

Authors:  Hongsen Bi; Hui Li; Chen Zhang; Yiqing Mao; Fangfei Nie; Ying Xing; Wuga Sha; Xi Wang; David M Irwin; Huanran Tan
Journal:  Stem Cell Res Ther       Date:  2019-10-17       Impact factor: 6.832

Review 7.  ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension.

Authors:  Tadeu L Montagnoli; Jaqueline S da Silva; Susumu Z Sudo; Aimeé D Santos; Gabriel F Gomide; Mauro P L de Sá; Gisele Zapata-Sudo
Journal:  Cells       Date:  2021-06-30       Impact factor: 7.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.